CMS To Let MA Use Step-Therapy For Doctor-Administered Drugs; Pit Prices In Part B, Part D Against Each Other

August 07, 2018
Medicare Advantage plans for the first time next year will be allowed to make beneficiaries use the cheapest doctor-administered drugs first, and step therapy could be used across doctor-administered drugs and retail drugs, but plans also must share half of savings from step therapy with beneficiaries, administration officials said Tuesday (Aug. 7). The combination of policies is both new and in keeping with the administration’s goal to let plans negotiate drug prices in Part B with use-management tools and to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.